If you or a loved one were diagnosed with adenocarcinoma of colon or rectum after taking Zantac (Ranitidine), you may be entitled to recover compensation from a Zantac colon adenocarcinoma lawsuit case or settlement claim.
A team of heartburn drug injury lawyers and class action attorneys is investigating potential lawsuit and settlement cases of individuals who were diagnosed with adenocarcinoma of the colon or rectum after taking Zantac (Ranitidine) for heartburn.
Rectal or colon adenocarcinoma is a type of colorectal cancer that forms when epithelial cells of the lining inside the large intestine change and grow out of control, forming a cancerous or malignant mass known as a tumor. Adenocarcinomas usually begin as non-cancerous tissue growths called polyps. Adenocarcinomas of the colon and rectum are the most common form of colorectal cancer, accounting for over 95 percent of all rectal and colon cancer cases.
Zantac Colon Adenocarcinoma Lawsuit Cases
Zantac colon adenocarcinoma lawsuit and settlement cases potentially being investigated include claims of individuals who took Zantac that was recalled and suffered serious injuries, side-effects or complications including, among others:
- Colorectal adenocarcinoma
- Adenocarcinoma of the colon
- Adenocarcinoma of the rectum
- Classical adenocarcinoma (AC)
- Mucinous colorectal adenocarcinoma (colloid) (MAC)
- Colorectal primary signet ring cell carcinoma (PSRCCR)
Most colorectal adenocarcinomas are characterized as classical adenocarcinomas. Some less common colorectal adenocarcinomas can include mucinous colorectal adenocarcinomas and colorectal signet ring cell adenocarcinomas.
Mucinous colorectal adenocarcinoma is an aggressive type of colorectal cancer characterized by the presence of extracellular mucin or mucos (comprising more than 50% of the tumor volume) that can cause cancer cells to grow and spread faster. Mucinous colorectal adenocarcinomas make up about 10-15 percent of all rectal and colon adenocarcinomas.
Colorectal primary signet ring cell carcinoma or signet ring cell adenocarcinoma is an aggressive cancer characterized by presence of abundant intracytoplasmic mucin and peripherally displaced nuclei, causing them to appear like signet rings (comprising more than 50% signet-ring cells). Colorectal signet ring cell carcinoma is rare, accounting for about 1% of all colorectal adenocarcinomas and is often diagnosed at an advanced stage due to the late manifestation of symptoms.
If you or someone you love took Zantac and suffered from adenocarcinoma of the colon or rectum, you may be entitled to recover compensation from a Zantac colon adenocarcinoma lawsuit case or settlement claim. Contact a drug injury lawyer to request a free case review.
*If you or a loved one are experiencing health issues, side effects or complications after taking a prescription drug or medication, we urge you to promptly consult with your doctor or physician for an evaluation.
**The listing of a company (e.g., Sandoz, Pfizer, GlaxoSmithKline, Sanofi, Apotex, Perrigo, Lannett or Novitium) or product (e.g., Zantac or Ranitidine) is not meant to state or imply that the company acted illegally or improperly or that the product is unsafe or defective; rather only that an investigation may be, is or was being conducted to determine whether legal rights have been violated.
***The use of any trademarks, tradenames or service marks is solely for product identification and/or informational purposes.
Fill out the form for a free attorney review.